Alexia Rouland

1.1k total citations
29 papers, 618 citations indexed

About

Alexia Rouland is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, Alexia Rouland has authored 29 papers receiving a total of 618 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Surgery and 7 papers in Epidemiology. Recurrent topics in Alexia Rouland's work include Diabetes Treatment and Management (7 papers), Diabetes Management and Research (6 papers) and Diet, Metabolism, and Disease (5 papers). Alexia Rouland is often cited by papers focused on Diabetes Treatment and Management (7 papers), Diabetes Management and Research (6 papers) and Diet, Metabolism, and Disease (5 papers). Alexia Rouland collaborates with scholars based in France, Switzerland and Canada. Alexia Rouland's co-authors include Bruno Vergès, Benjamin Bouillet, Jean‐Michel Petit, Laurence Duvillard, Romaric Loffroy, Anne-Laure Sberna, Thomas Mouillot, Damien Denimal, Patrick Hillon and M.-C. Brindisi and has published in prestigious journals such as Diabetes Care, Arteriosclerosis Thrombosis and Vascular Biology and International Journal of Obesity.

In The Last Decade

Alexia Rouland

25 papers receiving 612 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexia Rouland France 11 293 290 128 119 104 29 618
Hangkai Huang China 12 246 0.8× 150 0.5× 56 0.4× 69 0.6× 63 0.6× 33 425
Muammer Kara Türkiye 15 425 1.5× 152 0.5× 79 0.6× 155 1.3× 129 1.2× 37 654
Myrto Eliades United States 6 350 1.2× 222 0.8× 125 1.0× 124 1.0× 50 0.5× 7 733
Emanuele Muraca Italy 12 263 0.9× 163 0.6× 49 0.4× 51 0.4× 108 1.0× 25 446
K. Lucas United Kingdom 7 332 1.1× 265 0.9× 97 0.8× 61 0.5× 88 0.8× 13 528
Noriyuki Kitagawa Japan 14 115 0.4× 96 0.3× 86 0.7× 103 0.9× 79 0.8× 74 622
JANE HOLMES-WALKER Australia 3 835 2.8× 506 1.7× 141 1.1× 189 1.6× 217 2.1× 7 958
María Teresa Julián Spain 12 125 0.4× 220 0.8× 60 0.5× 127 1.1× 25 0.2× 26 374
A. Staccini‐Myx France 4 298 1.0× 97 0.3× 38 0.3× 116 1.0× 64 0.6× 5 722

Countries citing papers authored by Alexia Rouland

Since Specialization
Citations

This map shows the geographic impact of Alexia Rouland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexia Rouland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexia Rouland more than expected).

Fields of papers citing papers by Alexia Rouland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexia Rouland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexia Rouland. The network helps show where Alexia Rouland may publish in the future.

Co-authorship network of co-authors of Alexia Rouland

This figure shows the co-authorship network connecting the top 25 collaborators of Alexia Rouland. A scholar is included among the top collaborators of Alexia Rouland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexia Rouland. Alexia Rouland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rouland, Alexia, Philippe Thuillier, Abdallah Al‐Salameh, et al.. (2024). Smoking and diabetes. Annales d Endocrinologie. 85(6). 614–622. 3 indexed citations
2.
Mouillot, Thomas, Marie‐Claude Brindisi, Fabienne Liénard, et al.. (2024). Prolonged latency of the gustatory evoked potentials for sucrose solution in subjects living with obesity compared with normal-weight subjects. International Journal of Obesity. 48(12). 1720–1727. 1 indexed citations
3.
Vergès, Bruno, Marie‐Christine Vantyghem, Yves Reznik, et al.. (2024). Hypertriglyceridemia Results From an Impaired Catabolism of Triglyceride-Rich Lipoproteins in PLIN1 -Related Lipodystrophy. Arteriosclerosis Thrombosis and Vascular Biology. 44(8). 1873–1883. 1 indexed citations
4.
Rouland, Alexia, Thomas Gautier, Damien Denimal, et al.. (2024). The Endogenous Inhibitor of CETP, apoC1, Remains Ineffective In Vivo after Correction of Hyperglycemia in People with Type 1 Diabetes. Metabolites. 14(9). 487–487.
5.
Bouillet, Benjamin, Isabelle Simoneau, Sylvain Manfrédi, et al.. (2023). Glycemic control in people with diabetes treated with cancer chemotherapy: contribution of continuous glucose monitoring. Acta Diabetologica. 60(4). 545–552. 3 indexed citations
6.
Denimal, Damien, Alexia Rouland, Benjamin Bouillet, et al.. (2023). Plasma ceramides are associated with MRI-based liver fat content but not with noninvasive scores of liver fibrosis in patients with type 2 diabetes. Cardiovascular Diabetology. 22(1). 310–310. 8 indexed citations
7.
Denimal, Damien, Isabelle Simoneau, Laurent Demizieux, et al.. (2023). Liraglutide reduces plasma dihydroceramide levels in patients with type 2 diabetes. Cardiovascular Diabetology. 22(1). 104–104. 15 indexed citations
8.
Rouland, Alexia, et al.. (2023). Concise review of lipidomics in nonalcoholic fatty liver disease. Diabetes & Metabolism. 49(3). 101432–101432. 21 indexed citations
9.
Tramunt, Blandine, Alexia Rouland, Vincent Durlach, et al.. (2023). Smoking and Diabetes: Sex and Gender Aspects and Their Effect on Vascular Diseases. Canadian Journal of Cardiology. 39(5). 681–692. 7 indexed citations
10.
11.
Donadieu, Jean, Blandine Beaupain, Jean‐François Viallard, et al.. (2022). ELANE neutropenia and solid tumors: Four cases from the French severe chronic neutropenia registry. Pediatric Blood & Cancer. 69(11). e29923–e29923.
12.
Bardou, Marc, Alexia Rouland, Myriam Martel, et al.. (2022). Review article: obesity and colorectal cancer. Alimentary Pharmacology & Therapeutics. 56(3). 407–418. 55 indexed citations
13.
Durlach, Vincent, Bruno Vergès, Abdallah Al‐Salameh, et al.. (2022). Smoking and diabetes interplay: A comprehensive review and joint statement. Diabetes & Metabolism. 48(6). 101370–101370. 70 indexed citations
14.
15.
Vergès, Bruno, Laurence Duvillard, Jean-Paul Paı̈s de Barros, et al.. (2021). Liraglutide Increases the Catabolism of Apolipoprotein B100–Containing Lipoproteins in Patients With Type 2 Diabetes and Reduces Proprotein Convertase Subtilisin/Kexin Type 9 Expression. Diabetes Care. 44(4). 1027–1037. 32 indexed citations
16.
Rouland, Alexia, et al.. (2021). Successful Control of Hypoglycemia with Pasireotide LAR in a Patient with Inappropriate Insulin Secretion. Clinical Pharmacology Advances and Applications. Volume 13. 33–37. 3 indexed citations
17.
Vergès, Bruno, Jean‐Michel Petit, Isabelle Simoneau, et al.. (2021). Fewer Type A personality traits in type 2 diabetes patients with diabetic foot ulcer. Diabetes & Metabolism. 47(6). 101245–101245. 4 indexed citations
18.
Vergès, Bruno, Alexia Rouland, Benjamin Bouillet, et al.. (2021). Liraglutide reduces plasma PCSK9 in patients with type 2 diabetes not treated with statins. Diabetes & Metabolism. 48(2). 101284–101284. 7 indexed citations
19.
Vergès, Bruno, Alexia Rouland, S. Baillot-Rudoni, et al.. (2020). Increased body fat mass reduces the association between fructosamine and glycated hemoglobin in obese type 2 diabetes patients. Journal of Diabetes Investigation. 12(4). 619–624. 5 indexed citations
20.
Rouland, Alexia, P. Buffier, Jean-Marc Petit, Bruno Vergès, & Benjamin Bouillet. (2020). Thyroïdites : où en est-on en 2019 ?. La Revue de Médecine Interne. 41(6). 390–395. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hangkai Huang Breakdown of academic impact, for papers by Muammer Kara Breakdown of academic impact, for papers by Myrto Eliades Breakdown of academic impact, for papers by Emanuele Muraca Breakdown of academic impact, for papers by K. Lucas Breakdown of academic impact, for papers by Noriyuki Kitagawa Breakdown of academic impact, for papers by JANE HOLMES-WALKER Breakdown of academic impact, for papers by María Teresa Julián Breakdown of academic impact, for papers by A. Staccini‐Myx
Rankless by CCL
2026